Deep Medicine Acquisition Corp. (DMAQ) Stock Overview
Explore Deep Medicine Acquisition Corp.’s financial performance, market position, analyst ratings, and future outlook.
Deep Medicine Acquisition Corp. (DMAQ)
Key Financials
Key Financials
Market Cap
12.9M
P/E Ratio
-0.09
EPS (TTM)
$-0.13
ROE
-2.92%
DMAQ Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Deep Medicine Acquisition Corp. (NASDAQ: DMAQ) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Deep Medicine Acquisition Corp.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of DMAQ on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $11.64 for the NASDAQ listing.
Key metrics behind Deep Medicine Acquisition Corp.'s NASDAQ-traded stock include a P/E ratio of -0.09 and a market capitalization of 12.9M. Combined with our AI analysis, these give both institutional and retail investors a clear view of DMAQ on the NASDAQ.